FY2022 EPS Estimates for Quipt Home Medical Corp. (NASDAQ:QIPT) Decreased by Analyst

Quipt Home Medical Corp. (NASDAQ:QIPTGet Rating) – Stock analysts at Leede Jones Gab dropped their FY2022 earnings per share estimates for shares of Quipt Home Medical in a research note issued on Tuesday, June 7th. Leede Jones Gab analyst D. Loe now forecasts that the company will post earnings of $0.17 per share for the year, down from their previous estimate of $0.19. Leede Jones Gab also issued estimates for Quipt Home Medical’s FY2024 earnings at $0.40 EPS.

Quipt Home Medical (NASDAQ:QIPTGet Rating) last issued its quarterly earnings results on Monday, May 16th. The company reported $0.14 EPS for the quarter, beating analysts’ consensus estimates of $0.03 by $0.11. The company had revenue of $33.55 million for the quarter, compared to analyst estimates of $35.05 million. Quipt Home Medical had a return on equity of 3.33% and a net margin of 6.63%. During the same period in the previous year, the company posted $0.02 earnings per share.

Several other analysts have also issued reports on the company. Raymond James set a $9.00 price objective on Quipt Home Medical and gave the company an “outperform” rating in a research note on Thursday, April 28th. Zacks Investment Research raised Quipt Home Medical from a “strong sell” rating to a “hold” rating in a research report on Wednesday, March 9th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $9.30.

QIPT opened at $5.10 on Friday. Quipt Home Medical has a 52-week low of $4.00 and a 52-week high of $6.99. The firm has a market capitalization of $171.16 million and a PE ratio of 20.40. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.13 and a current ratio of 1.54. The business’s 50-day simple moving average is $4.59 and its 200 day simple moving average is $5.05.

Several institutional investors and hedge funds have recently modified their holdings of QIPT. Royal Bank of Canada bought a new position in shares of Quipt Home Medical during the 2nd quarter worth approximately $35,000. Marshall Wace LLP purchased a new position in Quipt Home Medical in the fourth quarter worth $89,000. Acadian Asset Management LLC lifted its stake in Quipt Home Medical by 1,709,900.0% in the first quarter. Acadian Asset Management LLC now owns 17,100 shares of the company’s stock worth $75,000 after purchasing an additional 17,099 shares during the last quarter. Citadel Advisors LLC bought a new stake in Quipt Home Medical in the fourth quarter worth $97,000. Finally, Bank of America Corp DE raised its stake in shares of Quipt Home Medical by 196.7% during the fourth quarter. Bank of America Corp DE now owns 18,545 shares of the company’s stock valued at $104,000 after acquiring an additional 12,295 shares during the last quarter. Institutional investors own 19.42% of the company’s stock.

About Quipt Home Medical (Get Rating)

Quipt Home Medical Corp. provides in-home medical equipment and supplies, and respiratory and durable medical equipment in the United States. The company also offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions.

Featured Stories

Earnings History and Estimates for Quipt Home Medical (NASDAQ:QIPT)

Receive News & Ratings for Quipt Home Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quipt Home Medical and related companies with MarketBeat.com's FREE daily email newsletter.